The prevalence of anxiety and depression in people with age-related macular degeneration: A systematic review of observational study data

BMC Ophthalmology

Volumn 14, Issue 1, 2014, Pages

  Dawson, Sarah R ^a   Mallen, Christian D ^a   Gouldstone, Matthew B ^a   Yarham, Robert ^a   Mansell, Gemma ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Anxiety; Depression; Epidemiology; Macular degeneration; Prevalence

Indexed keywords

ANXIETY; COMPLICATION; DEPRESSION; HEALTH; HUMAN; MACULAR DEGENERATION; MENTAL HEALTH; OBSERVATIONAL STUDY; PREVALENCE; PSYCHOLOGY;

ANXIETY; DEPRESSION; GLOBAL HEALTH; HUMANS; MACULAR DEGENERATION; MENTAL HEALTH; OBSERVATIONAL STUDIES AS TOPIC; PREVALENCE;

EID: 84904399637     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-14-78     Document Type: Article

References (38)

1. Age related macular degeneration. Chopdar A, Chakravarthy U, Verma D, BMJ 2003 326 485 488 (Pubitemid 36269633)
2. Pegaptanib and Ranibizumab: Final Protocol. Colquitt J, 2006 [Accessed 01.02.2009]. [ http://www.nice.org.uk/nicemedia/pdf/Final-protocol-age-mac- degen.pdf ]
3. Burden of illness of neovascular age-related macular degeneration in Canada. Cruess A, Zlateva G, Xu X, Rochon S, Can J Ophthalmol 2007 42 6 836 843
4. The effect of visual and hearing impairments on functional status. Keller BK, Morton JL, Thomas VS, Potter JF, J Am Geriatr Soc 1999 47 1319 1325 (Pubitemid 29523202)
5. Depression and disability in elderly persons with impaired vision: a follow up study. Rovner BW, Zisselman P, Schmuely Y, J Am Geriat Soc 1996 44 181 184
6. 5.7 times more expensive than liquid gold. Bowler GS, Fayers T, Gouws P, Br J Ophthalmol 2011 95 308 317
7. Avastin versus Lucentis. Godlee F, BMJ 2012 344 3162
8. Mental health statistics: The most common mental health problems. Mental Health Foundation, [Accessed 14.03.2014]. [ http://www.mentalhealth.org.uk/help- information/mental-health-statistics/common-mental-health-problems/ ]
9. Prevalence of common mental disorders in general practice attendees across Europe. King M, Nazareth I, Levy G, Walker C, Morris R, Weich S, Bellón-Saameño JA, Moreno B, Švab I, Rotar D, Rifel J, Maaroos H-I, Aluoja A, Kalda R, Neeleman J, Geerlings MI, Xavier M, de Almeida Caldas M, Correa B, Torres-Gonzalez F, Br J Psychiatry 2008 192 362 367 (Pubitemid 351692381)
10. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Sareen J, Jacobi F, Cox BJ, Belik S-L, Clara I, Stein MB, Arch Intern Med 2006 166 19 2109 2116 (Pubitemid 44631399)
11. Anxiety disorders and comorbid mental illness. Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJG, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK, Stein MB, Gen Hosp Psychiatry 2008 30 208 225 (Pubitemid 351545834)
12. Anxiety, depression, and quality of life in primary care patients. Brenes GA, Prim Care Companion J Clin Psychiatry 2007 9 6 437 443 (Pubitemid 350278283)
13. Neuroticism predicts depression and disability in age-related macular degeneration. Rovner BW, Casten RJ, J Am Geriatr Soc 2001 49 8 1097 1100 (Pubitemid 32801149)
14. Effect of depression on vision function in age-related macular degeneration. Rovner BW, Casten RJ, Tasman WS, Arch Ophthalmol 2002 120 8 1041 1044 (Pubitemid 34856071)
15. The impact of depression in older adults with age-related macular degeneration. Casten RJ, Rovner BW, Edmonds SE, J Vis Impair Blind 2002 96 399 406 (Pubitemid 34747189)
16. Quality of life in age-related macular degeneration: a review of the literature. Mitchell J, Bradley C, Health Qual Life Outcomes 2006 4 97
17. Quality of life in patients with age-related macular degeneration: impact of the condition and benefits of treatment. Slakter JS, Stur M, Surv Ophthalmol 2005 50 3 263 273 (Pubitemid 40602738)
18. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group, Ann Intern Med 2009 151 4 264 269
19. Burden and health care resource utilization in neovascular age-related macular degeneration. Soubrane G, Cruess A, Lotery A, Pauleikhoff D, Monés J, Xu X, Zlateva G, Buggage R, Conlon J, Goss TF, Arch Ophthalmol 2007 125 9 1249 1254 (Pubitemid 47403034)
20. Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study. Lotery A, Xu X, Zlateva G, Loftus J, Br J Ophthalmol 2007 91 1303 1307 (Pubitemid 47492861)
21. Burden of illness of bilateral neovascular age-related macular degeneration in Spain. Ruiz-Moreno JM, Coco RM, García-Arumí J, Xu X, Zlateva G, Curr Med Res Opin 2008 24 7 2103 2111
22. Depression despite anti-vascular endothelial growth factor treatment of age-related macular degeneration. Casten R, Rovner BW, Leiby BE, Tasman W, Arch Ophthalmol 2010 128 506 508
23. Depressive symptoms and quality of life in people with age-related macular degeneration. Mathew RS, Delbaere K, Lord SR, Beaumont P, Vaegan, Madigan MC, Ophthalmic Physiol Opt 2011 31 4 375 380
24. Longitudinal incidence of adverse outcomes of age-related macular degeneration. Wysong A, Lee PP, Sloan FA, Arch Ophthalmol 2009 127 3 320 327
25. Explaining the relationship between three eye diseases and depressive symptoms in older adults. Popescu ML, Boisjoly H, Schmaltz H, Kergoat M-J, Rousseau J, Maghadazadeh S, Djafari F, Freeman EE, Invest Ophthalmol Vis Sci 2012 53 4 2308 2313
26. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Brody BL, Gamst AC, Williams RA, Smith AR, Lau PW, Dolnak D, Rapaport MH, Kaplan RM, Brown SI, Ophthalmology 2001 108 10 1893 1901
27. Activity loss and depression in age-related macular degeneration. Rovner BW, Casten RJ, Am J Geriatr Psychiatry 2002 10 3 305 310 (Pubitemid 34517685)
28. Anxiety and depression prevalence rates in age-related macular degeneration. Augustin A, Sahel JA, Bandello F, Dardennes R, Maurel F, Negrini C, Hieke K, Berdeaux G, MICMAC Study Group, Invest Ophthalmol Vis Sci 2007 48 4 1498 1503 (Pubitemid 351261331)
29. The role of control in depression, anxiety, and life satisfaction among visually impaired older adults. Kleinschmidt JJ, Trunnell EP, Reading JC, White GL, Richardson GE, Egbert EM, J Health Educ 1995 26 1 26 36
30. Depressive symptoms and age-related macular degeneration in older people: the cardiovascular health study. Sun C, Tikellis G, Klein R, Steffens DC, Larsen EKM, Wong TY, Ophthalmic Epidemiol 2007 14 3 127 133 (Pubitemid 47026991)
31. The hospital anxiety and depression scale. Zigmond AS, Snaith RP, Acta Psychiatr Scand 1983 67 261 270
32. The CES-D scale: a self-reported depression scale for research in the general population. Radloff LS, Appl Psych Meas 1977 1 385 401
33. Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in the Netherlands. Beekman ATF, Deeg DJH, van Limbeek J, Braam AW, de Vries MZ, van Tilburg W, Psychol Med 1997 27 231 235 (Pubitemid 27042735)
34. Development and validation of a geriatric depression screening scale: a preliminary report. Yeasavage JA, Brink TL, Rose TL, J Psych Res 1983 17 1 37 49 (Pubitemid 13123113)
35. Detecting anxiety and depression in general medical settings. Goldberg D, Bridges K, Duncan-Jones P, Grayson D, BMJ 1998 297 897 899
36. The PHQ-9: validity of a brief depression severity measure. Kroenke K, Spitzer R, Williams J, J Gen Intern Med 2001 16 9 606 613 (Pubitemid 32823891)
37. Ranibizumab for neovascular age-related macular degeneration. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, N Engl J Med 2006 355 14 1419 1431 (Pubitemid 44511557)
38. Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008. Zhang X, Bullard KM, Cotch MF, Wilson R, Rovner BW, McGwin G, Owsley C, Barker L, Crews JE, Saaddine JB, JAMA Ophthalmol 2013 131 5 573 581